Brainstorm Cell Therapeutics Inc.
BCLI- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001137883
No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Brainstorm Cell Therapeutics Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 42 | 1 | 39 | −2 |
| Shares | 4.40M | 4.40K | 4.16M | −237.2K (−5.4%) |
| Value | $17.6M | $18.0K | $14.0M | −$3.61M (−20.5%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 94,600 | $318.0K | 0.00% |
| Group One Trading, L.P. | 49,097 | $165.0K | 0.00% |
| Jmac Enterprises LLC | 45,430 | $153.0K | 0.04% |
| IFP Advisors, Inc | 19,850 | $104.0K | 0.00% |
| Citadel Advisors LLC | 24,119 | $81.0K | 0.00% |
Sold out (7)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Sabby Management, LLC | 513,211 | $2.05M |
| Geneos Wealth Management Inc. | 10,100 | $40.0K |
| Bank Julius Baer & Co. Ltd, Zurich | 4,167 | $17.0K |
| Tower Research Capital LLC (TRC) | 3,442 | $14.0K |
| Cypress Capital Management LLC (WY) | 1,500 | $6.00K |
| Aquatic Capital Management LLC | 800 | $3.00K |
| CoreCap Advisors, LLC | 133 | $1.00K |
Not filed for Q1 2022 yet (1)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Harbour Investments, Inc. | 4,399 | $18.0K |